ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,387Medicare Part D Prescriptions Filled, Including Refills

Rank: 128 out of 890

$546K Total Retail Price of All Prescriptions

Rank: 220 out of 890

316 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 316 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 12,163 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 695 626 1 2
SIMVASTATIN 550 460 2 5
GABAPENTIN 547 486 3 12
AMLODIPINE BESYLATE 525 471 4 1
MELOXICAM 384 351 5 18
LOSARTAN POTASSIUM 342 313 6 29
FUROSEMIDE 337 306 7 7
LOVASTATIN 315 306 8 46
ALENDRONATE SODIUM 286 280 9 38
METFORMIN HCL 251 203 10 6
OMEPRAZOLE 249 220 11 8
METOPROLOL SUCCINATE 196 192 12 17
NEXIUM 187 187 13 14
HYDROCHLOROTHIAZIDE 181 166 14 9
GLIPIZIDE XL 181 139 14 128
LISINOPRIL 179 171 16 4
CITALOPRAM HBR 169 142 17 20
METOPROLOL TARTRATE 166 157 18 15
POTASSIUM CHLORIDE 163 147 19 11
TRAMADOL HCL 157 131 20 16
AMLODIPINE BESYLATE-BENAZEPRIL 149 149 21 41
CLONIDINE HCL 141 139 22 35
PRAVASTATIN SODIUM 135 122 23 10
ALLOPURINOL 129 116 24 31
WARFARIN SODIUM 125 125 25 24
DONEPEZIL HCL 121 121 26 30
RANITIDINE HCL 109 109 27 49
CARVEDILOL 109 94 27 22
GLIMEPIRIDE 104 82 29 27
GLIPIZIDE ER 102 97 30 110
SERTRALINE HCL 102 101 30 26
NAMENDA 99 86 32 36
CLOPIDOGREL 97 92 33 28
HYDROCODONE-ACETAMINOPHEN 96 80 S3 34 3
ATORVASTATIN CALCIUM 95 94 35 13
PREDNISONE 95 82 35 47
TAMSULOSIN HCL 92 79 37 32
PLAVIX 89 81 38 42
AZITHROMYCIN 86 71 39 37
CLOTRIMAZOLE-BETAMETHASONE 83 81 40 152
DIOVAN 82 60 41 33
LABETALOL HCL 76 76 42 208
LOSARTAN-HYDROCHLOROTHIAZIDE 76 75 42 57
METOCLOPRAMIDE HCL 75 67 44 125
GUANFACINE HCL 75 75 R 44 233
ALPRAZOLAM 74 61 46 95
DILTIAZEM HCL 74 74 46 235
PREMARIN 74 74 R 46 105
PAROXETINE HCL 74 73 46 68
ISOSORBIDE MONONITRATE ER 65 64 50 60
GEMFIBROZIL 65 54 50 103
FLUTICASONE PROPIONATE 63 60 52 39
TRIAMTERENE-HCTZ 62 58 53 61
SYNTHROID 60 60 54 53
VYTORIN 58 58 55 183
ADVAIR DISKUS 58 58 55 52
CIPROFLOXACIN HCL 57 48 57 58
TORSEMIDE 56 45 58 159
CRESTOR 54 44 59 25
ZETIA 54 33 59 81
NIFEDIPINE ER 51 51 61 75
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 51 61 21
QUINAPRIL HCL 50 46 63 116
MUPIROCIN 50 36 63 121
VENLAFAXINE HCL 50 46 63 287
SUCRALFATE 50 49 63 158
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.